CRC (Colorectal Cancer)

Oncology·MeSH: Colorectal Neoplasms

Prevalence

135.0 / 100K

Incidence

36.0 / 100K/yr

5 drugs in development·2 companies·7 clinical trials

Drug Pipeline by Phase

Phase 2(1)
DrugCompany
PM8002BioNTech SE (BNTX)

Compare drugs

Chemotherapy Regimen 1 vs Chemotherapy Regimen 2Chemotherapy Regimen 1 vs folfoxChemotherapy Regimen 1 vs inca33890

Frequently asked questions

How many drugs are in development for CRC (Colorectal Cancer)?

BioSniper tracks 5 drugs in development for CRC (Colorectal Cancer) across 2 companies.

How many clinical trials target CRC (Colorectal Cancer)?

There are 7 clinical trials targeting CRC (Colorectal Cancer) tracked by BioSniper.

What is the prevalence of CRC (Colorectal Cancer)?

The estimated prevalence of CRC (Colorectal Cancer) is approximately 135.0 per 100,000 population.

Deep-dive into CRC (Colorectal Cancer)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis